Are you ready for Startups Meet Pharma 2022? EIT Health has 4 challenges for you this year and they have Takeda, Boehringer Ingelheim, Sintetica SA – Innovating Therapies and Novartis ready to explore partnerships with you!

This year Takeda is looking into digital solutions that improve the diagnostic pathways for rare blood diseases, with a particular focus on improving testing for Thrombotic thrombocytopenic purpura (TTP), which is an ultra-rare, life-threatening blood disorder.

If you are working on pain management, from new types of pharmacological treatment, novel drug delivery routes, medical devices, to digital approaches, Sintetica is your partner.

Boehringer Ingelheim brings a challenge into the Chronic Kidney Disease area, looking for a digital diagnostic support tool that aids the diagnosis of new CKD patients, flags the unrecognized CKD patients and could be integrated with the daily workflow of GPs.

With Cardiovascular disease (CVD) being the leading cause of death worldwide, Novartis is exploring solutions or platforms that can support integrated care pathways, including any digital health interventions to optimize the patient outcome, reduce disease burden and minimize avoidable healthcare resource utilization for atherosclerotic cardiovascular disease patients.

For more information, check out more information about the challenges HERE and don’t forget to apply before March 14!